- Home
- Products
- Customized FluoroAb™
- GUCY2C
- Anti-GUCY2C MAb (Clone 1)-iFluor® 514 Succinimidyl Ester
Anti-GUCY2C MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11108)
- TARGET
- ANTIBODY
- DYE
- Name
- GUCY2C
- Alternative Names
- GUCY2C; DIAR6; GUC2C; MECIL; MUCIL; STAR; guanylate cyclase 2C; GC-C
- Overview
- Anti-GUCY2C antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 514 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 511/527
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS11108. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-403 | Anti-GUCY2C-MMAE ADC | Cleavable peptide linker | MMAE (Monomethyl auristatin E) |
| ADC-W-209 | Anti-GUCY2C-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-210 | Anti-GUCY2C-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-TNF MAb (Clone 6)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS707)
- Anti-VEGFA MAb (Clone 10)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS3087)
- Anti-CD22 MAb (Clone 12)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4950)
- Anti-EGFR MAb (Clone 20)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2384)
- Taplitumomab paptox-Coumarin (CAT#: ADC-FL-373)
- Anti-PDCD1 MAb (Clone 5)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9142)
- Anti-MST1R MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8149)
- Anti-MSLN MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS437)
- Anti-CD22 MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9393)
- Anti-DLL3 MAb (Clone 9)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5527)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
